| Mrs Rikki Karen Amesquita, SP/L | |
|
2058 Dorval Dr, Naperville, IL 60565-2110 | |
| (630) 548-2472 | |
| Not Available |
| Full Name | Mrs Rikki Karen Amesquita |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2058 Dorval Dr, Naperville, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023359437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.000198 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rikki Karen Amesquita, SP/L 2058 Dorval Dr, Naperville, IL 60565-2110 Ph: (630) 548-2472 | Mrs Rikki Karen Amesquita, SP/L 2058 Dorval Dr, Naperville, IL 60565-2110 Ph: (630) 548-2472 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has initiated a study for ISIS-DMPK Rx in patients with Myotonic Dystrophy Type 1 (DM1). DM1 is a rare genetic neuromuscular disease caused by the production of toxic dystrophia myotonica-protein kinase (DMPK) RNA in cells. ISIS-DMPKRx is specifically designed to reduce toxic DMPK RNA.
NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today the launch of its new 8 Series Electronic Health Record (EHR) Content, its most advanced EHR, boasting enhanced usability, configurability and adoptability.
The causes of 40 percent of all cases of certain medulloblastoma - dangerous brain tumors affecting children - are hereditary.
IsoRay, Inc. announced today that it has completed a license agreement with Hologic, Inc. for exclusive worldwide distribution rights to the GliaSite® radiation therapy system, the world's only FDA-cleared balloon catheter device used in the treatment of brain cancer. The system's balloon catheter is a landmark technology that allows physicians to treat more patients than ever before with brachytherapy or internal radiation and provides important benefits over other radiation treatment options.
It was November 2014, and I was working on a feature story about a buzzed-about blood-testing company in Silicon Valley that promised to "disrupt" the lab industry with new technology.
› Verified 7 days ago
Judith Anne Lawlor, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2652 Haddassah Dr, Naperville, IL 60565 Phone: 630-967-4742 | |
Jamie Mapel, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 603 E Diehl Rd Ste 123, Naperville, IL 60563 Phone: 630-428-1595 | |
Sasha Boheme, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 N Wright St, Naperville, IL 60540 Phone: 163-096-44107 | |
Amber Arvin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2156 Deep Water Ln, Naperville, IL 60564 Phone: 630-904-0700 | |
Paola Prado, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1804 Centre Point Cir, Naperville, IL 60563 Phone: 630-955-1940 | |
Maria M Marin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 846 Santa Maria Dr, Naperville, IL 60540 Phone: 630-922-9680 |